Schisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is a spectrum of liver lesions ranging from hepatic steatosis, nonalcoholic steatohepatitis, hepatic cirrhosis, and hepatocellular carcinoma. The high global prevalence of NAFLD has underlined the important public health implications of this disease. The path...
Main Authors: | Pou Kuan Leong, Kam Ming Ko |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2016/6171658 |
Similar Items
-
Differential Action between Schisandrin A and Schisandrin B in Eliciting an Anti-Inflammatory Action: The Depletion of Reduced Glutathione and the Induction of an Antioxidant Response.
by: Pou Kuan Leong, et al.
Published: (2016-01-01) -
Inflammasome: A Double-Edged Sword in Liver Diseases
by: Jingyun Luan, et al.
Published: (2018-09-01) -
Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis
by: Goh Eun Chung, et al.
Published: (2013-06-01) -
Schisandrin B as a Hormetic Agent for Preventing Age-Related Neurodegenerative Diseases
by: Philip Y. Lam, et al.
Published: (2012-01-01) -
C-Kit, a Double-Edged Sword in Liver Regeneration and Diseases
by: Weina Wang, et al.
Published: (2021-02-01)